46,218.60
0.00 BRL
837.37 M BRL
12.08 B BRL
About BioMarin Pharmaceutical Inc.
Sector
Industry
CEO
Alexander Hardy
Website
Headquarters
San Rafael
Founded
1997
ISIN
BRB1MRBDR001
FIGI
BBG00RD5Q2Y4
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
BMRN5187965
BioMarin Pharmaceutical Inc. 1.25% 15-MAY-2027Yield to maturity
4.87%
Maturity date
May 15, 2027
Explore more bonds
Curated watchlists where B1MR34 is featured.